Drug Trial Radar · NCT07248865
A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Feb 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Dec 2, 2025
Primary completion
Jul 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Climb Bio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase 1, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CLYM116 in healthy volunteers.
Conditions
- Healthy Volunteers
Interventions
CLYM116Drug
CLYM116 to be administered by SC injection
PlaceboDrug
Placebo solution to be administered at a matching volume by SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability of single and multiple ascending doses of CLYM116 in healthy volunteers Incidence of treatment-emergent adverse eventsTime frame: From Screening through to Day 85, or final follow-up visit
- Incidence of injection site reactions Number of injection site reactionsTime frame: From Baseline through to Day 4 and Day 15 to Day 18
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nucleus Network Brisbane
Brisbane, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.